NCT00600509View on ClinicalTrials.gov

Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method

PHASE2CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions
Epilepsy
Interventions
DRUG

Levetiracetam

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
collaborator

UCB Japan Co. Ltd.

INDUSTRY

lead

UCB Pharma

INDUSTRY